P. Tzonis

Development of a predictive model for luteal phase oocyte retrieval in poor responders undergoing natural cycle IVF

M. Koutsilieris, K. Pantos, M. Simopoulou, 2022, Scientific Reports.

Evaluating different strategies for poor ovarian response management: a retrospective cohort study and literature review

M. Koutsilieris, A. Philippou, K. Pantos, 2021, Annals of the New York Academy of Sciences.

Breast cancer and pregnancy; overview of international bibliography.

C. Sofoudis, P. Koutsouradis, K. Kalogerakos, 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide

S. Perez, M. Papamichail, C. Baxevanis, 2016, Journal of Immunotherapy for Cancer.

AE37 peptide vaccination in prostate cancer: a 4-year immunological assessment updates on a phase I trial

H. Kalbacher, S. Perez, C. Baxevanis, 2013, Cancer Immunology, Immunotherapy.

Introducing intrauterine antibiotic infusion as a novel approach in effectively treating chronic endometritis and restoring reproductive dynamics: a randomized pilot study

M. Koutsilieris, K. Pantos, M. Simopoulou, 2021, Scientific Reports.

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

E. Mittendorf, G. Peoples, S. Perez, 2015, Journal of Immunotherapy for Cancer.

Oncology Breast cancer surgery in the elderly women: A review

C. Sofoudis, K. Kalogerakos, P. Tzonis, 2014 .

Subgroup efficacy evaluation of the AE37 HER2 vaccine in breast cancer patients in the adjuvant setting.

E. Mittendorf, G. Peoples, J. Litton, 2017 .